两组患者的1个治疗周期结束后的药物不良反应被记录，包括红细胞（RBC）

The adverse drug reactions of the two groups of patients after the end of a treatment cycle were recorded, including red blood cell (RBC) reduction, gastrointestinal reactions, white blood cell (WBC) reduction, liver function damage and other adverse reactions;

Adverse drug reactions were recorded after the end of 1 treatment cycle in two groups of patients, including adverse reactions such as reduced red blood cells (RBC), gastrointestinal reactions, reduced white blood cells (WBC), and impaired liver function;

Adverse drug reactions were recorded after one treatment cycle in two groups, including red blood cell (RBC) decrease, gastrointestinal reaction, white blood cell (WBC) decrease, liver function injury and other adverse reactions;<br>